Centiva Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.51M Buy
+554,800
New +$6.63M 0.07% 207
2025
Q3
Sell
-47,243
Closed -$457K 1627
2025
Q2
$457K Buy
+47,243
New +$487K 0.01% 998
2024
Q4
Sell
-28,372
Closed -$543K 2188
2024
Q3
$543K Buy
+28,372
New +$588K 0.01% 1202
2023
Q4
Sell
-31,736
Closed -$551K 2117
2023
Q3
$551K Buy
+31,736
New +$662K 0.01% 918

Other funds holding OGN

Centiva Capital's OGN Position: Q2 2026 in Review

Centiva Capital opened a new position in Organon & Co (OGN) in Q2 2026: 554,800 shares worth $7.51M. The stake represents 0.07% of the portfolio and ranks #207 among its holdings. This is a return to the name: Centiva Capital previously reported a position in OGN as recently as Q2 2025.

Centiva Capital first reported a position in OGN in Q3 2023 and has held it in 4 quarters since. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Centiva Capital held 554,800 shares of Organon & Co worth $7.51M as of Q2 2026.
  • Organon & Co was a new Centiva Capital position in Q2 2026.
  • Organon & Co made up 0.07% of Centiva Capital's portfolio in Q2 2026, its #207 holding.
  • Centiva Capital first reported a position in Organon & Co in Q3 2023 and has held it in 4 quarters since.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.